GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Attenuates Cerebral Ischemia Injury In Vivo and Vitro by Differential Modulations of NMDA Receptors Subunit Components at Different Post-Ischemia Stage in Mice.
Front Aging Neurosci
; 9: 186, 2017.
Article
in En
| MEDLINE
| ID: mdl-28649199
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Front Aging Neurosci
Year:
2017
Document type:
Article
Affiliation country:
Country of publication: